Related Experiment Video

Updated: Aug 25, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells

Jean-Claude Dumon1, Fabrice Journé, Naïma Kheddoumi

  • 1Laboratory of Endocrinology and Bone Diseases, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. lmetabos@ulb.ac.be

European Urology
|March 26, 2004
PubMed
Abstract

Insights

Aminobisphosphonates, particularly zoledronic acid, significantly inhibit prostate cancer cell growth by inducing cytostatic and apoptotic effects. This finding supports their use in managing bone metastases in prostate cancer patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Bisphosphonates are established bone resorption inhibitors for breast cancer and myeloma.
  • Zoledronic acid demonstrates potential in reducing skeletal morbidity in prostate cancer.

Purpose of the Study:

  • To investigate the biological impact of various bisphosphonates on prostate cancer cell line PC-3.
  • To compare the cytostatic and apoptotic effects of clodronate, pamidronate, ibandronate, and zoledronic acid.

Main Methods:

  • PC-3 cell survival assessed via MTT assay and DNA content analysis.
  • Four bisphosphonates tested at concentrations from 10(-6) to 10(-4) M.
  • Cell cycle progression and apoptosis were evaluated using multiple methods.

Main Results:

  • Clodronate showed minimal impact on PC-3 cell growth.
  • Aminobisphosphonates significantly reduced cell growth in a time- and dose-dependent manner.
  • Zoledronic acid exhibited pronounced apoptotic effects, alongside cytostatic actions common to all aminobisphosphonates.

Conclusions:

  • Aminobisphosphonates, with zoledronic acid being particularly effective, markedly inhibit PC-3 cancer cell proliferation.
  • These inhibitory effects involve a combination of cytostatic and apoptotic mechanisms.
  • The findings suggest a potential role for bisphosphonates in treating prostate cancer bone metastases.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...